Description: Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.
Home Page: www.mankindpharma.com
262, Okhla Industrial Estate
New Delhi,
110 020
India
Phone:
91 11 4654 1111
Officers
| Name | Title |
|---|---|
| Mr. Ramesh C. Juneja | Executive Chairman |
| Mr. Sheetal Arora | CEO & Whole-Time Director |
| Mr. Rajeev Juneja | Vice Chairman & MD |
| Mr. Satish Kumar Sharma | Whole-Time Director |
| Mr. Ashutosh Dhawan MBA | Chief Financial Officer |
| Mr. Arjun Juneja | Chief Operating Officer |
| Mr. Chanakya Juneja | Director of Technology |
| Mr. Pramod Gokhale | President - Group Chief Information Officer |
| Dr. Anil Kumar | Chief Scientific Officer (Research Centre) |
| Mr. Abhishek Agarwal | Head of Investor Relations |
Exchange: BSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 49.981 |
| Price-to-Book MRQ: | 9.8038 |
| Price-to-Sales TTM: | 9.5856 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 19540 |